HighPoint Advisor Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.23M Sell
2,924
-22
-0.7% -$8.77K 0.04% 282
2026
Q2
$1.07M Buy
2,946
+460
+19% +$157K 0.04% 308
2026
Q1
$875K Sell
2,486
-11,807
-83% -$4.21M 0.04% 315
2025
Q4
$4.68M Buy
14,293
+11,986
+520% +$3.8M 0.1% 179
2025
Q3
$651K Buy
2,307
+36
+2% +$10.4K 0.03% 351
2025
Q2
$634K Sell
2,271
-67
-3% -$19K 0.03% 321
2025
Q1
$729K Sell
2,338
-9,952
-81% -$2.94M 0.04% 277
2024
Q4
$3.63M Sell
12,290
-321
-3% -$95.2K 0.2% 90
2024
Q3
$4.06M Buy
12,611
+106
+0.8% +$34.7K 0.24% 71
2024
Q2
$4.17M Buy
12,505
+1,248
+11% +$367K 0.25% 72
2024
Q1
$3.47M Buy
11,257
+333
+3% +$97.4K 0.25% 71
2023
Q4
$3.07M Sell
10,924
-231
-2% -$62.9K 0.22% 83
2022
Q2
$2.74M Sell
11,155
-3,009
-21% -$737K 0.3% 65
2021
Q3
$3.01M Buy
14,164
+654
+5% +$151K 0.3% 69
2021
Q2
$3.29M Buy
13,510
+1,059
+9% +$261K 0.33% 62
2021
Q1
$3.1M Sell
12,451
-197
-2% -$47K 0.36% 60
2020
Q4
$2.99M Buy
12,648
+7,747
+158% +$1.79M 0.36% 60
2020
Q3
$1.14M Sell
4,901
-418
-8% -$104K 0.21% 97
2020
Q2
$1.36M Buy
5,319
+310
+6% +$70.7K 0.29% 76
2020
Q1
$1.18M Sell
5,009
-2,763
-36% -$604K 0.28% 71
2019
Q4
$1.85M Buy
7,772
+2,796
+56% +$616K 0.38% 60
2019
Q3
$1.1M Sell
4,976
-625
-11% -$120K 0.24% 81
2019
Q2
$985K Sell
5,601
-74
-1% -$13.2K 0.23% 86
2019
Q1
$986K Sell
5,675
-1,286
-18% -$246K 0.24% 86
2018
Q4
$1.3M Buy
6,961
+813
+13% +$159K 0.34% 62
2018
Q3
$1.22M Sell
6,148
-70
-1% -$13.8K 0.33% 68
2018
Q2
$1.22M Buy
6,218
+1,705
+38% +$302K 0.33% 71
2018
Q1
$832K Sell
4,513
-2,089
-32% -$383K 0.23% 117
2017
Q4
$1.16M Sell
6,602
-157
-2% -$27.8K 0.33% 76
2017
Q3
$1.16M Buy
6,759
+993
+17% +$176K 0.36% 66
2017
Q2
$1M Hold
5,766
– – 0.32% 74
2017
Q1
$1M Buy
5,766
+2,741
+91% +$455K 0.32% 74
2016
Q4
$539K Buy
3,025
+351
+13% +$52.8K 0.17% 158
2016
Q3
$393K Buy
2,674
+89
+3% +$15K 0.14% 181
2016
Q2
$445K Buy
2,585
+1,005
+64% +$156K 0.16% 160
2016
Q1
$258K Sell
1,580
-47
-3% -$6.98K 0.16% 151
2015
Q4
$254K Buy
+1,627
New +$256K 0.17% 156

Other funds holding AMGN

HighPoint Advisor Group's AMGN Position: Q3 2026 in Review

HighPoint Advisor Group reduced its Amgen (AMGN) stake by 0.75% in Q3 2026, selling an estimated $8.77K and leaving 2,924 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #282.

HighPoint Advisor Group first reported a position in AMGN in Q4 2015 and has held it in 37 quarters since. The position peaked at $4.68M in Q4 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • HighPoint Advisor Group held 2,924 shares of Amgen worth $1.23M as of Q3 2026.
  • HighPoint Advisor Group sold 22 Amgen shares in Q3 2026, an estimated $8.77K.
  • Amgen made up 0.04% of HighPoint Advisor Group's portfolio in Q3 2026, its #282 holding.
  • HighPoint Advisor Group first reported a position in Amgen in Q4 2015 and has held it in 37 quarters since.
  • HighPoint Advisor Group's Amgen position peaked at $4.68M in Q4 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on HighPoint Advisor Group's 13F filing for Q3 2026, filed 9 Nov 2026.